- Carole Leach-Lemens | 07 August 2014
Integrating
intimate partner violence (IPV) prevention strategies into HIV prevention
programming led to a significant reduction in HIV incidence and in women’s
experience of physical and sexual violence from intimate partners in Rakai,
Uganda, ...
- Carole Leach-Lemens | 30 July 2014
Although Malawi’s policy of
offering lifelong antiretroviral therapy (ART) to women living with HIV who are pregnant or breastfeeding resulted in a sevenfold increase in women receiving ART in
15 months, implementers ...
- Mara Kardas-Nelson | 30 July 2014
Two
presentations given at the 20th International AIDS Conference (AIDS 2014), held in
Melbourne, Australia, provide significant evidence that harm
reduction programmes successfully prevent HIV infection among people who inject
drugs (PWID). Other barriers ...
- Mara Kardas-Nelson | 30 July 2014
Presentations
given at a session considering HIV prevention strategies among female sex
workers, which took place at the 20th International AIDS
Conference (AIDS 2014) in Melbourne, Australia, show that while consistent condom use ...
- Liz Highleyman | 29 July 2014
People who switch away from their initial
antiretroviral therapy (ART) regimen when their viral load is undetectable may
have a higher likelihood of subsequent virological failure, researchers
reported at the 20th International AIDS ...
- Roger Pebody | 29 July 2014
Surveys of gay men in the Netherlands and Australia suggest
that some would use condoms less frequently if they were taking PrEP – but that
these men are generally not using condoms ...
- Liz Highleyman | 29 July 2014
The quadrivalent human
papillomavirus (HPV) vaccine worked as well for teens and young adults living with HIV
as it did for their HIV-negative counterparts, according to study findings
presented the 20th International AIDS ...
- Roger Pebody | 28 July 2014
Self-testing for HIV has great potential to
broaden access to HIV testing, the 20th International AIDS
Conference in Melbourne heard last week. But for self-testing to play a key
role in reducing undiagnosed ...
- Gus Cairns | 28 July 2014
A survey of young gay men and transgender women in
Bangkok has found that HIV incidence is running at 9% a year in those
who don’t use condoms consistently – and 2% ...
- Gus Cairns | 26 July 2014
If there was a phrase that defined the 20th International AIDS
Conference (AIDS 2014), one that surfaced in every few presentations and kept turning up in
documents, it was “key affected populations”.Although ...
- Liz Highleyman | 25 July 2014
People with HIV in the normal weight range who gain a substantial amount of weight shortly
after starting antiretroviral therapy (ART) may have an increased risk of
cardiovascular disease and diabetes, according ...
- Liz Highleyman | 25 July 2014
People with chronic
hepatitis C who are using methadone or buprenorphine to manage opiate addiction
can be safely and effectively treated with AbbVie's 3D all-oral direct-acting
antiviral regimen plus ribavirin, resulting in a ...
- Roger Pebody | 25 July 2014
Three-quarters of Australian gay and bisexual men who report
unprotected anal intercourse with casual male partners say that they “often” or
“always” employ some sort of risk reduction strategy with those partners. ...
- Liz Highleyman | 25 July 2014
People who use
antiretroviral regimens containing efavirenz (Sustiva or Stocrin, also
in the Atripla coformulation) were
not at higher risk for impaired neurocognitive function, either overall or when
looking at specific functional domains, researchers ...
- Gus Cairns | 25 July 2014
Interviews with participants in the US sites of the iPrEx
study of pre-exposure prophylaxis (PrEP) show that participants who took it mainly
used it as an additional source of reassurance rather than ...
- Roger Pebody | 25 July 2014
The probability of gay men in England having unprotected
anal intercourse is strongly associated with the number of recreational drugs
they have taken at the time, according to a study presented to ...
- Roger Pebody | 25 July 2014
Scientific advances in biomedical prevention and treatment will not reach transgender people,
men who have sex with men (MSM) and other populations with the greatest needs without
parallel efforts to improve human ...
- Lesley Odendal | 24 July 2014
The
projected demand for antiretroviral therapy (ART) will increase to 16.8 million person-years by the end
of 2016 in low- and middle-income countries, including 15.7 million
person-years of adult and 1.1 million person-years ...
- Gus Cairns | 24 July 2014
A study presented at the 20th International AIDS Conference (AIDS 2014) in
Melbourne today compared the HIV epidemics in gay men in San Francisco, US and
London, UK and confirmed that while ...
- Liz Highleyman | 24 July 2014
Antiretroviral regimens
containing the recently approved HIV integrase inhibitor dolutegravir (Tivicay) demonstrated high rates of
viral suppression even in treatment-experienced people who had virus with resistance to NRTIs. Among people starting treatment ...
Antiretroviral drug chartA one-page reference guide to the anti-HIV drugs licensed for use in the UK or European Union, with information on formulation, dosing, key side effects and food requirements.
Your next stepsA booklet with information for people who’ve just found
out they have HIV.
Coming soon: news from IAS 2019 05 July 2019The 10th International AIDS Society
conference (IAS 2019) is being held...
Those who are not seen are not heard 01 July 2019A commentary on Optimising the Impact of Key Population Programming...
The fight for access to abortion care in Europe 27 June 2019Access to
sexual and reproductive health and rights includes safe and...